News

Brief news reports on Tuberculosis

Malawi on right track in fight against TB

National Tuberculosis and Leprosy Elimination Program (NTLEP) has disclosed that Malawi so far is doing well in the fight against TB.

Read More →

Open access TB publications

 

Read More →

Global TB Caucus: Platform of Experts - Implementing the Multisectoral accountability framework

The Global TB Caucus will host the second meeting of the Platform of Experts on 2 December 2021. The meeting will be centered on the need to implement the Multisectoral accountability framework, focusing particularly on the parliamentarians' checklist developed by the Global TB Caucus and piloted in the Eastern Europe and Central Asia region.

Read More →

Stop TB Partnership: Official side-event at Tokyo Nutrition for Growth Summit 2021

The Stop TB Partnership will host an official side-event, Undernutrition causes 20% of world’s TB cases. What to do?, at Tokyo Nutrition for Growth Summit 2021 on 6 December 2021.

Read More →

India has the highest population with household exposure to pulmonary TB

India has the highest population with household exposure to pulmonary tuberculosis (TB), and therefore an increased risk of infection, a new study published in The Lancet November 21, 2021, flagged.

Read More →

WHO #EndTB webinar on preventing and addressing TB-related disabilities and improving quality of life

To mark the United Nations International Day of Persons with Disabilities, the World Health Organization (WHO) will host a special webinar, Preventing and addressing TB-related disabilities and improving quality of life, on 2 December 2021.

Read More →

Missing in action: Why children are not getting TB treatment

Every day, more than 650 children around the world die from tuberculosis – largely because they have never had the chance to be diagnosed and treated. 

Read More →

How the pathogen Mycobacterium tuberculosis secretes and trafficks its only known exotoxin

Six years ago, Michael Niederweis, Ph.D., described the first known toxin of the deadly pathogen Mycobacterium tuberculosis (Mtb), an exotoxin that had gone undetected for 132 years. 

Read More →

Improved TB tests and treatments are vital to overcoming drug resistance

In the face of the COVID-19 pandemic, tuberculosis mortality has started to increase for the first time in a decade. In 2020 alone, more than 1.5 million people died from TB. Every year, about half a million people develop a drug-resistant form of TB (DR-TB).

Read More →

What’s new in the TB section of the 2021 WHO Model Lists of Essential Medicines

24 November 2021 | Geneva -- The World Health Organization’s (WHO’s) 2021 Model Lists of Essential Medicines feature key updates to the TB section including the addition of moxifloxacin and rifapentine for the indication of drug susceptible TB, child friendly formulations of bedaquiline and delamanid to treat drug resistant TB and a higher dose formulation of rifapentine for TB preventive treatment. Further updates include the addition of other TB medicines to the list as well as the removal of some TB medicines that are no longer considered essential. The revised list provides a comprehensive list of quality assured TB medicines for TB preventive treatment as well as for the treatment of drug susceptible and drug resistant TB. 

Read More →

Page 2 of 778 · Total posts: 10

←First 1 2 3 Last→